Advisory Committees
-
Briefing Information for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
FDA
Disclaimer
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552)
-
-







